Wilms' tumour: connecting tumorigenesis and organ development in the kidney (Q36234726)

12 August 2017

1 reference

title

Wilms' tumour: connecting tumorigenesis and organ development in the kidney (English)

1 reference

12 August 2017

Miguel N Rivera

1

1 reference

12 August 2017

Daniel A Haber

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

12 August 2017

published in

Nature Reviews Cancer

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

9

1 reference

12 August 2017

page(s)

699-712

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1696

12 August 2017

exact match

0 references

cites work

Recent advances in Wilms tumor genetics

1 reference

Relaxation of imprinted genes in human cancer.

21 January 2018

1 reference

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

21 January 2018

1 reference

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

21 January 2018

1 reference

An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor

21 January 2018

1 reference

The candidate Wilms' tumour gene is involved in genitourinary development

21 January 2018

1 reference

WT-1 is required for early kidney development

21 January 2018

1 reference

Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome

21 January 2018

1 reference

Donor splice-site mutations in WT1 are responsible for Frasier syndrome

21 January 2018

1 reference

Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms.

21 January 2018

1 reference

Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome

21 January 2018

1 reference

Identical genetic changes in different histologic components of Wilms' tumors.

21 January 2018

1 reference

Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development

21 January 2018

1 reference

Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition

21 January 2018

1 reference

Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia.

21 January 2018

1 reference

WNT and beta-catenin signalling: diseases and therapies

21 January 2018

1 reference

Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis

21 January 2018

1 reference

WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour

21 January 2018

1 reference

Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12–q21

21 January 2018

1 reference

Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome

21 January 2018

1 reference

An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome

21 January 2018

1 reference

Loss of heterozygosity for the short arm of chromosome 7 in sporadic Wilms tumour.

21 January 2018

1 reference

Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors

21 January 2018

1 reference

Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region

21 January 2018

1 reference

A mammal-specific exon of WT1 is not required for development or fertility

21 January 2018

1 reference

Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties

21 January 2018

1 reference

Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology

21 January 2018

1 reference

The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma

21 January 2018

1 reference

Wilms' tumour gene 1 (WT1) in human neoplasia.

21 January 2018

1 reference

A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization

21 January 2018

1 reference

DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1

21 January 2018

1 reference

Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product

21 January 2018

1 reference

A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1.

21 January 2018

1 reference

Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions.

21 January 2018

1 reference

A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1

21 January 2018

1 reference

Ciao 1 is a novel WD40 protein that interacts with the tumor suppressor protein WT1

21 January 2018

1 reference

Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.

21 January 2018

1 reference

Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control

21 January 2018

1 reference

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

21 January 2018

1 reference

The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin

21 January 2018

1 reference

E-cadherin is a WT1 target gene

21 January 2018

1 reference

The receptor tyrosine kinase regulator Sprouty1 is a target of the tumor suppressor WT1 and important for kidney development

21 January 2018

1 reference

WT1 regulates the expression of the major glomerular podocyte membrane protein Podocalyxin

21 January 2018

1 reference

The major podocyte protein nephrin is transcriptionally activated by the Wilms' tumor suppressor WT1.

21 January 2018

1 reference

The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1.

21 January 2018

1 reference

The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation

21 January 2018

1 reference

The Wilms' tumor gene Wt1 is required for normal development of the retina

21 January 2018

1 reference

Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing

21 January 2018

1 reference

Presence of WT1, the Wilm's tumor suppressor gene product, in nuclear poly(A)(+) ribonucleoprotein

21 January 2018

1 reference

Identification of WTAP, a novel Wilms' tumour 1-associating protein

21 January 2018

1 reference

RNA binding by the Wilms tumor suppressor zinc finger proteins.

21 January 2018

1 reference

Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation

21 January 2018

1 reference

WT1 proteins: functions in growth and differentiation

21 January 2018

1 reference

21 January 2018

The complex life of WT1

2 references

21 January 2018

inferred from DOI database lookup

7 January 2021

based on heuristic

Wilms tumor and the WT1 gene

1 reference

Initial differentiation of the metanephric mesenchyme is independent of WT1 and the ureteric bud

21 January 2018

1 reference

Sprouty1 is a critical regulator of GDNF/RET-mediated kidney induction

21 January 2018

1 reference

The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo.

21 January 2018

1 reference

YAC transgenic analysis reveals Wilms' tumour 1 gene activity in the proliferating coelomic epithelium, developing diaphragm and limb.

21 January 2018

1 reference

The Wilms tumor suppressor gene wt1 is required for development of the spleen.

21 January 2018

1 reference

WT1 is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis

21 January 2018

1 reference

A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome

21 January 2018

1 reference

A mutant form of the Wilms' tumor suppressor gene WT1 observed in Denys-Drash syndrome interferes with glomerular capillary development

21 January 2018

1 reference

Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis

21 January 2018

1 reference

WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts

21 January 2018

1 reference

The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells

21 January 2018

1 reference

Role of the WT1 tumor suppressor in murine hematopoiesis

21 January 2018

1 reference

Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiation.

21 January 2018

1 reference

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

21 January 2018

1 reference

Transcriptional regulation of IGF-I receptor gene expression by novel isoforms of the EWS-WT1 fusion protein

21 January 2018

1 reference

Induction of the interleukin-2/15 receptor beta-chain by the EWS-WT1 translocation product.

21 January 2018

1 reference

Induction of BAIAP3 by the EWS-WT1 chimeric fusion implicates regulated exocytosis in tumorigenesis.

21 January 2018

1 reference

Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein

21 January 2018

1 reference

Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors

21 January 2018

1 reference

CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors

21 January 2018

1 reference

Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4

21 January 2018

1 reference

Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.

21 January 2018

1 reference

Wnt-6 is expressed in the ureter bud and induces kidney tubule development in vitro

21 January 2018

1 reference

Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric branching during metanephric kidney development.

21 January 2018

1 reference

Uniparental paternal disomy in a genetic cancer-predisposing syndrome

21 January 2018

1 reference

The history of cancer epigenetics

21 January 2018

1 reference

A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting.

21 January 2018

1 reference

Parental imprinting of the mouse H19 gene

21 January 2018

1 reference

Monoallelic expression of the human H19 gene

21 January 2018

1 reference

Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome

21 January 2018

1 reference

Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15

21 January 2018

1 reference

Loss of imprinting of a paternally expressed transcript, with antisense orientation to KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is independent of insulin-like growth factor II imprinting

21 January 2018

1 reference

A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome

21 January 2018

1 reference

Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects

21 January 2018

1 reference

Coordinating early kidney development: lessons from gene targeting

21 January 2018

1 reference

Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome

21 January 2018

1 reference

Cell surface glypicans are low-affinity endostatin receptors

21 January 2018

1 reference

Endostatin regulates branching morphogenesis of renal epithelial cells and ureteric bud.

21 January 2018

1 reference

Recent genetic studies of mouse kidney development

21 January 2018

1 reference

Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia

21 January 2018

1 reference

Renal and neuronal abnormalities in mice lacking GDNF

21 January 2018

1 reference

Defects in enteric innervation and kidney development in mice lacking GDNF

21 January 2018

1 reference

Renal agenesis and the absence of enteric neurons in mice lacking GDNF

21 January 2018

1 reference

Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret

21 January 2018

1 reference

Haploinsufficiency of NSD1 causes Sotos syndrome

21 January 2018

1 reference

Clonality and loss of heterozygosity of WT genes are early events in the pathogenesis of nephroblastomas

21 January 2018

1 reference

Infrequent mutation of theWT1 gene in 77 Wilms' tumors

21 January 2018

1 reference

Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions

21 January 2018

1 reference

Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour

21 January 2018

1 reference

Tumour-suppressor activity of H19 RNA

21 January 2018

1 reference

21 January 2018

1 reference

Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor

31 March 2020

1 reference

Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts

31 March 2020

1 reference

Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor

31 March 2020

1 reference

Expression of the Wilms' tumor gene WT1 in the murine urogenital system

31 March 2020

1 reference

ASSOCIATION OF WILMS'S TUMOR WITH ANIRIDIA, HEMIHYPERTROPHY AND OTHER CONGENITAL MALFORMATIONS

31 March 2020

1 reference

Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour

31 March 2020

1 reference

Mutation and cancer: statistical study of retinoblastoma

31 March 2020

1 reference

IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome

31 March 2020

1 reference

Fine structure analysis of the WT1 gene in sporadic Wilms tumors

31 March 2020

1 reference

Loss of Imprinting of Insulin-Like Growth Factor-II (IGF2) Gene in Distinguishing Specific Biologic Subtypes of Wilms Tumor

31 March 2020

1 reference

Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations

31 March 2020

1 reference

A gene expression signature for relapse of primary wilms tumors

31 March 2020

1 reference

Chromosome 1q expression profiling and relapse in Wilms' tumour

31 March 2020

1 reference

Aniridia-Wilms’ tumor association: evidence for specific deletion of 11p13

31 March 2020

1 reference

Alternative splicing and genomic structure of the Wilms tumor gene WT1

31 March 2020

1 reference

Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence

31 March 2020

1 reference

A non-AUG translational initiation event generates novel WT1 isoforms

31 March 2020

1 reference

RNA editing in the Wilms' tumor susceptibility gene, WT1

31 March 2020

1 reference

WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion

31 March 2020

1 reference

Evidence that WT1 mutations in Denys — Drash syndrome patients may act in a dominant-negative fashion

31 March 2020

1 reference

Loss of WT1 function leads to ectopic myogenesis in Wilms' tumour

31 March 2020

1 reference

New developments in the pathology of Wilms tumor

31 March 2020

1 reference

A second transcriptionally active DNA-binding site for the Wilms tumor gene product, WT1

31 March 2020

1 reference

WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis

31 March 2020

1 reference

Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70

31 March 2020

1 reference

Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain

31 March 2020

1 reference

SUMO-1 modification of the Wilms' tumor suppressor WT1

31 March 2020

1 reference

The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis

31 March 2020

1 reference

Physical and functional interaction between WT1 and p53 proteins

31 March 2020

1 reference

Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9

31 March 2020

1 reference

WT1 activates a glomerular-specific enhancer identified from the human nephrin gene

31 March 2020

1 reference

Truncated WT1 mutants alter the subnuclear localization of the wild-type protein

31 March 2020

1 reference

WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes

31 March 2020

1 reference

G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes

31 March 2020

1 reference

A rodent model for Wilms tumors: embryonal kidney neoplasms induced by N-nitroso-N'-methylurea

31 March 2020

1 reference

Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants

31 March 2020

1 reference

Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor

31 March 2020

1 reference

The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour

31 March 2020

1 reference

Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome

31 March 2020

1 reference

Chromosome 11 uniparental isodisomy predisposing to embryonal neoplasms

31 March 2020

1 reference

Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours

31 March 2020

1 reference

Parental genomic imprinting of the human IGF2 gene

31 March 2020

1 reference

Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes

31 March 2020

1 reference

Epigenetic lesions at the H19 locus in Wilms' tumour patients

31 March 2020

1 reference

Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour

31 March 2020

1 reference

Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neoplasia

31 March 2020

1 reference

Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung

31 March 2020

1 reference

Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome

31 March 2020

1 reference

The Simpson-Golabi-Behmel gene, GPC3, is not involved in sporadic Wilms tumorigenesis

31 March 2020

1 reference

A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye

31 March 2020

1 reference

Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1696

1 reference

Dimensions Publication ID

12 August 2017

1034028024

0 references

1 reference